RE:DesperationYes, this bond was wrong, but it could have been worse - the dilution is still limited. I think the new CFO has done a good job and the company is now in a good position with its new products and pharma licences. But yes, if the rumour is true and Labs now wants to enter the leisure market, it won't suppose well. But I think rumours are being spread here deliberately to write off the new management again. In the future, the leisure market will be tiny compared to the pharmaceutical market, and Labs is playing there. Hold on to your shares...